Sort
141,003 grants matching “cytokine”
Supraphysiologic Shear Stresses Associated with Cardiopulmonary Bypass are Sufficient to Activate RIKP3 Signaling
$829,782Vishal Nigam · Seattle Children'S Hospital · R01 · FY2022 · HD
Biomarker Investigations for Clinical Trials
$829,776Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Inflammatory and Immune Mechanisms of Atherosclerosis in HIV-Infected Women
$829,735Robert C Kaplan · Albert Einstein College Of Medicine · R01 · FY2010 · HL
Reducing Arterial Inflammation and Improving Metabolic Health by Dual CCR2 and CCR5 Antagonism in People Living with HIV
$829,709Janet Lo · Massachusetts General Hospital · R01 · FY2020 · HL
MEKK3 signaling in hemogenic endothelium
$829,654Mark L Kahn · University Of Pennsylvania · R01 · FY2018 · HL
Dipyridamole as a Modulator of HIV-1 Inflammation by Adenosine Regulation
$829,507Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2015 · AI
Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection.
$829,283Cecile Tremblay · Centre Hospitalier De L'Universite De Montreal (University Of Montreal Hospital) · R01 · FY2025 · AG
Defining HIV reservoirs that rebound following suspension of ART
$829,247Lisa M Frenkel · Seattle Children'S Hospital · R01 · FY2017 · AI
Role of the innate immune defenses in viral infections
$829,217Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
$829,213Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2019 · AI
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
$829,213Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
$829,213Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2023 · AI
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
$829,213Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2022 · AI
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
$829,213Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Fibroblast orchestration of the immune response in pancreatic cancer
$829,209Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · U01 · FY2023 · CA
Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis
$829,097Brian F Volkman · Xlock Biosciences, Llc · R44 · FY2021 · AR
Prevalence & Pathogenesis of Pulmonary Disease in a Large Multicenter HIV Cohort
$829,058Alison Morris · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · HL
Attenuating Inflammation to Restore GI Tract Integrity and Reduce Viral Reservoirs During cART
$829,058Jacob D Estes · Oregon Health & Science University · R01 · FY2018 · DK
Cartilage Development and Disease
$829,023Yoshihiko Yamada · Dental & Craniofacial Research · Z01 · FY2007 · DE
Targeting Macrophages in Aging SIV-Infected Rhesus Macaques
$828,942Elizabeth Schmidt Didier · Tulane University Of Louisiana · R01 · FY2017 · HL
Molecular Imaging of Platelets and Oxidative Stress in Atherosclerosis
$828,766Jonathan R Lindner · Oregon Health & Science University · R01 · FY2019 · HL
Study of Aging Latinas/os for Understanding Dementia in HIV (SALUD HIV)
$828,637Monica G Rivera-Mindt · Fordham University · R01 · FY2021 · AG
RANDOMIZED CLINICAL TRIAL OF ETANERCEPT IN WEGENER'S
$828,621Johns Hopkins University · N01 · FY2000 · AR
Project 2
$828,618Jeroen Roose · University Of California, San Francisco · P01 · FY2017 · AI
Stress, Weathering, and Blood-Based Biomarkers of Alzheimerâs Disease
$828,609Steven R Beach · University Of Georgia · R01 · FY2025 · AG